Alzamend Neuro, Inc.
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, wh…
Biotechnology
US, Atlanta [HQ]
Growth Rates · Payout · Yield
Dividends Over Time
Growth Rates · Payout · Yield
Growth Rates
0.00%
YoY
0.00%
3Yr
0.00%
5Yr
0.00%
10Yr
Key Metrics
- -%
TTM Yield
- -
Average Days Gap
Series
% - -
Yield
0.00%
Payout Ratio
History
We could not find any dividend history for Alzamend Neuro, Inc..